Speakers

- David Chen
- Managing Director
- BFC Group

- Toby Freyman
- Vice President, Business Development
- Alexion Pharmaceuticals

- Dan Zheng
- Senior Director for Oncology Business Development,Center for External Innovation
- Takeda

- Christopher Hupp
- Senior Director, External Innovation
- Chemistry, Ipsen

- Maha Radhakrishnan
- Executive Partner
- Sofinnova Investments

- Grace Han McMahon
- Associate Vice President and Head, Pacific Business Development & Licensing
- MSD

- Harish Soundararajan
- Vice President
- Roivant Sciences

- Johan Verbeeck
- Vice President Business Development
- Johnson & Johnson Innovative Medicine

- Mitchell Zhang
- Vice President
- BFC Group

- Henry He
- Partner
- Fangda Partners

- Adrianne L.Wong
- Director, Oncology Search & Evaluation of Global Business Development
- Daiichi Sankyo

- Michael Tung
- MD, Chief Financial Officer
- vTv Therapeutics

- Yuan Mi
- Founder/COO
- CytosinLab Therapeutics

- Tess Cameron
- Principal
- RA Capital

- Venkatesan Raghavan
- Executive Director Search & Evaluation – Oncology
- Novartis

- René Fuertig
- Global Head of Neuroscience & Mental Health BD+L
- Boehringer Ingelheim

- Guoxin Zhu
- Vice President, Molecule Discovery, Lilly Research Laboratories
- Eli Lilly and Company

- Tomohiro Yamauchi
- Executive Director, Global Head of Scouting & Transaction Oncology
- Astellas

- Josh Shin
- Partner
- Fangda Partners

- Cynthia Wang
- Director, Global Business Development, Asia-Pacific Region
- Servier
Register
Brochure